Crossmark

Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review

Crossref DOI link: https://doi.org/10.1007/s12185-022-03504-8

Published Online: 2022-12-06

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gao, Li

Lu, Jun

Li, Jie

Hu, Yixin

Lu, Ye

Du, Weiwei

Hu, Shaoyan https://orcid.org/0000-0002-5183-2259
Funding

Funding for this research was provided by:

Jiangsu Key Project (No.BE2021654)

Suzhou Project (No.GSWS2020039)

National Clinical Research Center for Hematological Disorders (No.2020ZKPB02)
License Information

Text and Data Mining valid from 2022-12-06

Version of Record valid from 2022-12-06
More Information

Article History

Received: 31 March 2022

Revised: 28 November 2022

Accepted: 28 November 2022

First Online: 6 December 2022

Declarations

:

: The authors declare that they have no conflict of interest.

: The studies involving human participants were reviewed and approved by Ethics Committee of Children’s Hospital of Soochow University. Written informed consent to participate in this study was provided by the participant’s legal guardian/next of kin.

Document is current

Any future updates will be listed below